"MSK Nassau offers the same expert cancer care patients expect from Memorial Sloan Kettering, just closer to home. Patients are able to receive much of their treatment — including chemotherapy, immunotherapy, and radiation therapy — at our location in Uniondale, New York. For general information, call Memorial Sloan Kettering at 212-639-2000, 24 hours a day, seven days a week. To make an appointment, call us at 833-494-2758, Monday through Friday between 8:00 AM and 6:00 PM ET."

During the past decade, Memorial Sloan Kettering Nassau conducted 273 clinical trials. In the 10-year time frame, 273 clinical trials started and 65 clinical trials were completed, i.e. on average, 23.8% percent of trials that started reached the finish line to date. In the past 5 years, 93 clinical trials started and 32 clinical trials were completed. i.e. 34.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Sloan Kettering Nassau" #1 sponsor was "Memorial Sloan Kettering Cancer Center" with 254 trials, followed by "National Cancer Institute (NCI)" with 49 trials sponsored, "Bristol-Myers Squibb" with 24 trials sponsored, "NRG Oncology" with 17 trials sponsored and "Alliance for Clinical Trials in Oncology" with 17 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan Kettering Nassau" #1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Merck Sharp & Dohme LLC" with 11 trials as a collaborator, "AstraZeneca" with 10 trials as a collaborator and "Bristol-Myers Squibb" with 10 trials as a collaborator. Other collaborators include 317 different institutions and companies that were collaborators in the rest 196 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Nassau" are "Breast Cancer" (34 trials), "Prostate Cancer" (16 trials), "Lung Cancer" (15 trials), "Multiple Myeloma" (13 trials) and "Head and Neck Cancer" (9 trials). Many other conditions were trialed in "Memorial Sloan Kettering Nassau" in a lesser frequency.

Most popular intervention types in "Memorial Sloan Kettering Nassau" are "Drug" (263 trials), "Other" (104 trials), "Radiation" (91 trials), "Procedure" (67 trials) and "Biological" (63 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (38 trials), "Quality-of-Life Assessment" (33 trials), "Questionnaire Administration" (23 trials), "Carboplatin" (21 trials) and "Cisplatin" (21 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan Kettering Nassau" are 301 trials for "All" genders, 73 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Sloan Kettering Nassau". undefined are not yet recruiting, 153 are recruiting, 154 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in Memorial Sloan Kettering Nassau, 2 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan Kettering Nassau, 76 "Phase 1" clinical trials were conducted, 189 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 26 trials that are defined as “Not Applicable".